Brief: Diasorin Receives Us' FDA 510(K) Clearance And Clia Waiver For Liaison Nes Group A Streptococcus (Gas) Assay
19/06/2026 14:59
BRIEF-Diasorin Receives Us' FDA 510(K) Clearance And Clia Waiver For Liaison Nes Group A Streptococcus (Gas) Assay June 19 (Reuters) - Diasorin SpA DIAS.MI:
RECEIVES US' FDA 510(K) CLEARANCE AND CLIA WAIVER FOR LIAISON NES GROUP A STREPTOCOCCUS (GAS) ASSAY
Further company coverage: DIAS.MI
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on DiaSorin SpA
See all newsBrief: Diasorin Receives Us' FDA 510(K) Clearance And Clia Waiver For Liaison Nes Group A Streptococcus (Gas) Assay
Deutsche Bank cuts Diasorin to 'sell', sees company targets as stretched
Italy - Factors to watch on June 5
Italy's DiaSorin jumps after Betaville reports possible takeover interest
Europe Research Roundup: Aj Bell, Greencore, S&U